Methylprednisolone After Traumatic Spinal Cord Injury: Yes or No?

PM and R

Volumn 1, Issue 7, 2009, Pages 669-673

  Liu, John C ^a   Patel, Alpesh ^b   Vaccaro, Alexander R ^c   Lammertse, Daniel P ^d   Chen, David ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c Regional Spinal Cord Injury System of the Delaware Valley   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE;

ADULT; ANAL SENSATION; ANKLE DORSIFLEXOR MUSCLE; AXILLA; CASE REPORT; CERVICAL SPINE; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DRUG MEGADOSE; EDITORIAL; EMERGENCY WARD; GASTROINTESTINAL DISEASE; HAND PARESTHESIA; HEAD; HIP FLEXOR MUSCLE; HUMAN; INFECTION RISK; KNEE EXTENSOR MUSCLE; MALE; MUSCLE; MUSCLE STRENGTH; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT TRANSPORT; PRIORITY JOURNAL; RIB FRACTURE; SENSATION; SENSORY DYSFUNCTION; SPINAL CORD COMPRESSION; SPINAL CORD INJURY; TRAFFIC ACCIDENT; UNCONSCIOUSNESS; VERTEBRA FRACTURE;

ACUTE DISEASE; GLUCOCORTICOIDS; HUMANS; METHYLPREDNISOLONE; PHYSICIAN'S PRACTICE PATTERNS; SPINAL CORD INJURIES;

EID: 67649528724     PISSN: 19341482     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmrj.2009.06.002     Document Type: Editorial

References (36)

1. Sekhor L.H., and Fehlings M.G. Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine 26 Suppl (2001) S2-S12
2. Amar P.A., and Levy M.L. Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury. Neurosurgery 44 (1999) 1027-1040
3. Fehlings M.G., and Perrin R.G. The role and timing of early decompression for cervical spinal cord injury: update with a review of recent clinical evidence. Injury 36 Suppl 2 (2005) B13-B26
4. Coleman W.P., Benzel D., Cahill D.W., et al. A critical appraisal of the reporting of the National Acute Spinal Cord Injury Studies (II and III) of methylprednisolone in acute spinal cord injury. J Spinal Disord 13 (2002) 185-199
5. Tator C.H. Biology of neurological recovery and functional restoration after spinal cord injury. Neurosurgery 42 (1998) 696-708
6. Bracken M.B., Sheppard M.J., Collins W.F., et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 322 (1990) 1405-1411
7. Bracken M.B., Sheppard M.J., Holford T.R., et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. JAMA 277 (1997) 1597-1604
8. Poynton A.R., O'Farrell D.A., Shannon F., et al. An evaluation of the factors affecting neurological recovery following spinal cord injury. Injury 28 (1997) 545-548
9. Burns A.S., and Ditunno J.F. Establishing prognosis and maximizing functional outcomes after spinal cord injury: a review of current and future directions in rehabilitation management. Spine 26 Suppl (2001) S137-S145
10. Roberts I., Yates D., Sandercock P., et al. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomized placebo-controlled trial. Lancet 364 (2004) 1321-1328
11. Bracken M.B., Collins W.F., Freeman D.F., et al. Efficacy of methylprednisolone in acute spinal cord injury. JAMA 251 (1984) 45-52
12. Bracken M.B., Shepard M.J., Hellenbrand K.G., et al. Methylprednisolone and neurological function 1 year after spinal cord injury. Results of the National Acute Spinal Cord Injury Study. J Neurosurg 63 (1985) 704-713
13. Bracken M.B., Shepard M.J., Collins Jr. W.F., et al. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the Second National Acute Spinal Cord Injury Study. J Neurosurg 76 (1992) 23-31
14. Bracken M.B., Shepard M.J., Holford T.R., et al. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. J Neurosurg 89 (1998) 699-706
15. Bracken M.B., Sheppard M.J., Collins W.F., et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 322 (1990) 1405-1411
16. Hurlbert R.J. Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J Neurosurg 93 1 Suppl (2000) 1-7
17. Young W., and Bracken M.B. The Second National Acute Spinal Cord Injury Study. J Neurotrauma 9 Suppl 1 (1992) S397-S405
18. Bracken M.B., Sheppard M.J., Holford T.R., et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 277 (1997) 1597-1604
19. Hadley M.N., Walters B.C., Grabb P.A., et al. Guidelines for the management of acute cervical spine and spinal cord injuries. Clin Neurosurg 49 (2002) 407-498
20. Hurlbert R.J., and Moulton R. Why do you prescribe methylprednisolone for acute spinal cord injury?. A Canadian perspective and a position statement. Can J Neurol Sci 29 (2002) 236-239
21. Hurlbert R.J., and Hamilton M.G. Methylprednisolone for acute spinal cord injury: 5-year practice reversal. Can J Neurol Sci 35 (2008) 41-45
22. Bracken M.B., Shepard M.J., Collins W.F., et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury: results of the second National Acute Spinal Cord Injury Trial. N Engl J Med 322 (1990) 1405-1411
23. Leary W.E. Treatment is said to reduce disability from spinal injury (March 31, 1990), New York Times
24. Gerhart K.A., Johnson R.L., Menconi J., Hoffman R.E., and Lammertse D.P. Utilization and effectiveness of methylprednisolone in a population-based sample of spinal cord injured persons. Paraplegia 33 (1995) 316-321
25. Nesathurai S. Steroids and spinal cord injury: revisiting the NASCIS 2 and NASCIS 3 trials. J Trauma 45 (1998) 1088-1093
26. Hurlbert R.J. Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J Neurosurg 93 1 Suppl (2000) 1-7
27. Short D.J., El Masry W.S., and Jones P.W. High dose methylprednisolone in the management of acute spinal cord injury-a systematic review from a clinical perspective. Spinal Cord 38 (2000) 273-286
28. Coleman W.P., Benzel E., Cahill D., et al. A critical reappraisal of the reporting of the National Acute Spinal Cord Injury Studies (II and III) of methylprednisolone in acute spinal cord injury. J Spinal Disord 13 (2000) 185-199
29. Sayer F.T., Kronvall E., and Nilsson O.G. Methylprednisolone treatment in acute spinal cord injury: the myth challenged through a structured analysis of published literature. Spine J 6 (2006) 335-343
30. Hadley M.N. Pharmacological therapy after acute cervical spinal cord injury. Neurosurgery 50 Suppl (2002) S63-S72
31. Bracken M.B. Comments. Neurosurgery 50 Suppl (2002) Sxiv-Sxix
32. Bracken M.B., and Holford T.R. Effect of timing of methylprednisolone or naloxone administration on recovery of segmental and long-tract neurological functions in NASCIS 2. J Neurosurg 79 (1993) 500-507
33. Hall E.D., and Springer J.E. Neuroprotection and acute spinal cord injury: a reappraisal. NeuroRx 1 (2004) 80-100
34. Hurlbert R.J., and Moulton R. Why do you prescribe methylprednisolone for acute spinal cord injury?. A Canadian perspective and position statement. Can J Neuro Sci 29 (2002) 236-239
35. Vellman W.P., Hawkes A.P., and Lammertse D.P. Administration of corticosteroids for acute spinal cord injury: the current practice of trauma medical directors and emergency medical system physician advisors. Spine 28 (2003) 941-947
36. Eck J.C., Nachtigall D., Humphreys S.C., and Hodges S.D. Questionnaire survey of spine surgeons on the use of methylprednisolone for acute spinal cord injury. Spine 31 (2006) E250-E253